This website uses cookies to enhance the user experience.
21st logo
||
A

ABRAXAS AS972 405 949

Limited company
Galeasen 7 1394 NESBRU, Norge

ABRAXAS AS

Operating
Investeringer i verdipapirer og andre finansielle instrumenter, herunder å delta i andre selskaper, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretagender. Investering i eiendom og andre aktiva. Yte rådgivingstjenester i forbindelse med etablering av virksomheter og deltagelse i styrearbeid.
Investerings- og rådgivningsvirksomhet.

Organization

CEO
Chairman of the board
Years since formation
31 years
since Mar 12, 1995
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
250,000
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2025
1,311,056
NOK
Total equity 2025
4,367,689
NOK
Last update: Aug 20, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Alternate Member-

Others

NameRoleShares
S
STIANSEN & CO AS
Auditor-
A
AK-REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
250,000
100 %

Shares owned by the ABRAXAS AS

NameShare classTotal number of sharesShare
A
APIM THERAPEUTICS AS
Ordinary shares
6,933
0.31 %
G
GENTIAN DIAGNOSTICS ASA
Ordinary shares
15,000
0.1 %
C
CIRCIO HOLDING ASA
Ordinary shares
141,922
0.1 %
O
ONCOINVENT ASA
Ordinary shares
225,535
0.05 %
A
ARCTIC BIOSCIENCE AS
Ordinary shares
12,500
0.05 %
N
NYKODE THERAPEUTICS ASA
Ordinary shares
137,809
0.04 %
E
ELLIPTIC LABORATORIES ASA
Ordinary shares
27,500
0.03 %
Z
ZELLUNA ASA
Ordinary shares
4,100
0.02 %
A
ANDFJORD SALMON GROUP AS
Ordinary shares
12,796
< 0.01 %
O
OTOVO ASA
Ordinary shares
6,000
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
1,311,056
-4,494,028
-1,909,328
-9,756,187
447,122
Total assets
5,117,888
4,306,059
8,686,880
11,164,086
22,914,576
Total liabilities
750,199
1,249,426
1,136,219
1,704,097
1,698,400
Total equity
4,367,689
3,056,633
7,550,662
9,459,989
21,216,176

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
112,513
133,168
143,718
154,926
213,986
Operating result
-112,513
-133,168
-143,718
-154,926
-213,986
Financial income/costs
1,423,569
-4,360,860
-1,765,609
-9,601,261
661,107
Profit before tax
1,311,056
-4,494,028
-1,909,328
-9,756,187
447,122
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
1,311,056
-4,494,028
-1,909,328
-9,756,187
447,122

Balance overview

Year20252024202320222021
Total fixed assets
3,000
3,000
3,000
3,000
3,000
Total current assets
5,114,888
4,303,059
8,683,880
11,161,086
22,911,576
Total assets
5,117,888
4,306,059
8,686,880
11,164,086
22,914,576
Short term debt
750,199
1,249,426
1,136,219
1,704,097
1,698,400
Long term debt
0
0
0
0
0
Total liabilities
750,199
1,249,426
1,136,219
1,704,097
1,698,400
Contributed capital
250,000
250,000
250,000
250,000
250,000
Retained earnings
4,117,689
2,806,633
7,300,662
9,209,989
20,966,176
Total equity
4,367,689
3,056,633
7,550,662
9,459,989
21,216,176
Total equity and liabilities
5,117,888
4,306,059
8,686,880
11,164,086
22,914,576

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification